AGP Executive Report
Last update: 6 hours agoFederal Medical Cannabis: The DEA has begun registering more than 900 state-licensed dispensaries in seven states under the Schedule III framework, a move that could unlock tax benefits. The agency says growers and distributors are still under review and warns dispensaries to source products only from federally registered companies. Oklahoma Rules: New edible regulations taking effect Nov. 1 require clearer THC serving labels and restrict shapes and packaging that could appeal to children; processors say uncertainty has made compliance costly. Hemp Restrictions: A federal ban on synthetic hemp cannabinoids is set to take effect Nov. 12, leaving hemp-drink businesses adjusting their plans. Research: A 35-year study raises doubts about marijuana as a sleep aid, while another report links medical cannabis treatment with lasting chronic-pain relief and reduced opioid use. Ballot Battles: Voters in Massachusetts and Idaho are set to consider measures that would restrict or roll back cannabis legalization.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
